Variant report
Variant | esv3429499 |
---|---|
Chromosome Location | chr13:84698951-84700974 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs552476365 | chr13:84698951-84698952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs116461194 | chr13:84698956-84698957 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs139294266 | chr13:84698957-84698958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs8000968 | chr13:84698967-84698968 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs564090164 | chr13:84698996-84698997 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs142582327 | chr13:84699060-84699061 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs574600925 | chr13:84699106-84699107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs191890995 | chr13:84699111-84699112 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs556980670 | chr13:84699135-84699136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs374966148 | chr13:84699136-84699137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs150952141 | chr13:84699151-84699152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs546112454 | chr13:84699161-84699162 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs553007138 | chr13:84699244-84699245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs12184517 | chr13:84699271-84699272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs184083257 | chr13:84699278-84699279 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs532967154 | chr13:84699326-84699327 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs4885908 | chr13:84699371-84699372 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs530664293 | chr13:84699412-84699413 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs115316582 | chr13:84699414-84699415 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs564140206 | chr13:84699449-84699450 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs187065962 | chr13:84699479-84699480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs563259414 | chr13:84699513-84699514 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs375065215 | chr13:84699563-84699564 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs60706770 | chr13:84699564-84699565 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs72233632 | chr13:84699565-84699566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs371946101 | chr13:84699566-84699567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs530749671 | chr13:84699580-84699581 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs59718007 | chr13:84699583-84699584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs397966038 | chr13:84699584-84699585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs552804158 | chr13:84699614-84699615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs576387124 | chr13:84699727-84699728 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs201665112 | chr13:84699752-84699753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs59157777 | chr13:84699763-84699764 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs66886222 | chr13:84699766-84699767 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs57275157 | chr13:84699767-84699768 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs35218582 | chr13:84699770-84699771 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs9531554 | chr13:84699771-84699772 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs9575522 | chr13:84699775-84699776 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs61213450 | chr13:84699779-84699780 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs552232197 | chr13:84699780-84699781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs58774395 | chr13:84699783-84699784 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs188937942 | chr13:84699785-84699786 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs72477643 | chr13:84699800-84699801 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs150078878 | chr13:84699820-84699821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs192227099 | chr13:84699827-84699828 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs554229375 | chr13:84699829-84699830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs539425865 | chr13:84699852-84699853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs544119379 | chr13:84699853-84699854 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs568209083 | chr13:84699855-84699856 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs185004652 | chr13:84699873-84699874 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Breast cancer | 21858162 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Developmental delay | 19490664 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Cancer | 17160897 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Epilepsy | 20502679 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:84693600-84700600 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
2 | chr13:84696000-84700800 | Weak transcription | NHEK | skin |
3 | chr13:84696200-84700600 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
4 | chr13:84696200-84700800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
5 | chr13:84700600-84701400 | Enhancers | Cortex derived primary cultured neurospheres | brain |
6 | chr13:84700600-84701400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
7 | chr13:84700600-84701800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr13:84700600-84702000 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
9 | chr13:84700800-84701200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
10 | chr13:84700800-84701400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
11 | chr13:84700800-84701600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
12 | chr13:84700800-84701600 | Enhancers | Esophagus | oesophagus |
13 | chr13:84700800-84701600 | Enhancers | NHEK | skin |
14 | chr13:84700800-84701800 | Enhancers | Primary T cells fromperipheralblood | blood |